O

ONWARD Medical

Develops ARC Therapy for spinal injury

Clinical Development Lead - Early Research

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeLausanne, SwitzerlandNo salary listed

About the Job

Requirements

  • An advanced degree in neuroscience or a related scientific or clinical discipline (PhD, MD, or equivalent); a Master's degree with substantial commensurate experience will be considered.
  • Meaningful experience in early-phase clinical research within medical devices, including direct involvement in investigator-initiated studies and/or early feasibility studies.
  • Ability to develop a deep, credible understanding of ONWARD's product platforms (ARC-EX, ARC-IM, and ARC-BCI), their mechanisms of action, and clinical applications.
  • Demonstrated success building and sustaining peer-level relationships with clinical investigators and key opinion leaders.
  • Working knowledge of regulatory frameworks governing clinical evidence generation (EU MDR, Good Clinical Practice, ISO 14155, GDPR/nDSG) and of market access and reimbursement evidence needs, sufficient to bridge the portfolio to Regulatory Affairs' and Market Access's strategies.
  • Strong organizational skills with the ability to manage multiple projects simultaneously and maintain clear portfolio visibility.
  • Excellent written and verbal communication skills, including the ability to distill complex clinical and scientific information for Marketing, Research and Development, Regulatory Affairs, and Market Access audiences.
  • Ability to work effectively across cultures and geographies, engaging external partners and internal cross-functional teams.
  • Represent the ONWARD Commitments.

Responsibilities

  • Partner with Upstream Marketing to translate strategic indication priorities into a coordinated clinical evidence plan that aligns the early-research portfolio (investigator-initiated studies, early feasibility studies, and grant-funded studies) across ARC-EX, ARC-IM, and ARC-BCI.
  • Assess the scientific merit, regulatory pathway, and commercial value of each study opportunity; partner with Regulatory Affairs to determine how evidence could support regulatory approval, inform progression to broader feasibility or pivotal trials, and guide study prioritization or disposition.
  • Incorporate input from Market Access on reimbursement and health-economic evidence needs so the portfolio generates data supporting regulatory approval and market access strategy.
  • Review the early-research portfolio against Marketing's strategic priorities and recommend and drive adjustments, including starting or stopping studies, consolidating single-center studies into multi-center programs, or redirecting resources toward higher-priority indications.
  • Identify evidence gaps required for regulatory approval of priority indications and coordinate next steps with Regulatory Affairs, Clinical Science, and Clinical Operations.
  • Serve as ONWARD's primary contact with investigators and key opinion leaders across the early-research portfolio, engaging as a scientific peer in study concepts, design discussions, and interpretation of results.
  • Build and sustain long-term scientific relationships with investigators and institutions, representing ONWARD as a scientific partner in the neuromodulation and spinal cord injury community.
  • Facilitate engagement between key opinion leaders and Clinical Science to support protocol development and study design, while remaining the primary relationship owner with investigators throughout the study lifecycle.
  • Provide scientific and strategic input to Clinical Science during protocol development, grounded in direct key opinion leader relationships and portfolio-level context.
  • Partner with Clinical Operations on study execution and site management, including contracts, budgets, and the Trial Master File.
  • Translate study outcomes and field and key opinion leader insights into structured recommendations for Upstream Marketing on future strategic indication priorities and therapy optimization, and for Research and Development on device requirements.
  • Participate in and help govern the Clinical Research Committee to maintain portfolio-level visibility and support study approval decisions.
  • Ensure clinical data, adverse events, device deficiencies, and field insight are captured and shared with cross-functional stakeholders in accordance with ONWARD's Quality Management System.
  • Analyze and summarize study data in collaboration with Clinical Science to inform pipeline development decisions and regulatory reporting.
  • Coordinate a portfolio-level publication and presentation strategy to ensure consistent, credible, and independent representation of ONWARD's early research.

Desired Qualifications

  • Prior clinical research experience in neuromodulation or spinal cord stimulation.
  • A track record of scientific publication and conference presentation in a relevant field.

About the Company

ONWARD Medical

Develops ARC Therapy for spinal injury

ONWARD Medical develops ARC Therapy, an investigational neurostimulation technology aimed at restoring movement for people with spinal cord injuries. The system uses targeted, programmed stimulation of the spinal cord to re-enable locomotion and may also improve bladder control, sexual function, and blood pressure. The company does not yet sell the device; it licenses its intellectual property and works with leading research institutions to advance its therapy. Unlike many competitors, ONWARD focuses on a proprietary spinal cord stimulation approach and a licensing-based business model built on strong academic partnerships. The ultimate goal is to obtain regulatory approval and commercialization of ARC Therapy to improve outcomes for patients with spinal cord injuries and support healthcare providers and institutions treating them.

Company size
201-500
Company stage
IPO
Headquarters
Eindhoven, Netherlands
Founded
2014

Recently Posted Jobs

Explore more opportunities at ONWARD Medical

See more jobs